Key result
Study evaluates second-generation DES length for associations with 2-year cardiovascular and bleeding events.
Why the study?
Does second-generation drug-eluting stent length affect cardiovascular and bleeding events in Japanese patients with ischemic heart disease?
Does second-generation drug-eluting stent length affect cardiovascular and bleeding events in Japanese patients with ischemic heart disease?
Answers are grounded in this paper and cite their sources.
This cohort study examines the association between second-generation drug-eluting stent length and cardiovascular and bleeding events in Japanese patients with ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Ejiri et al. (2020) studied this question. Second-generation drug-eluting stent length was investigated for its association with 2-year cardiovascular and bleeding events among Japanese patients with ischemic heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: